Hematological and renal toxicity in mice after three cycles of high activity [177Lu]Lu-PSMA-617 with or without human α1-microglobulin
Sign Up to like & getrecommendations! Published in 2024 at "Scientific Reports"
DOI: 10.1038/s41598-024-61370-2
Abstract: Radioligand therapy with [177Lu]Lu-PSMA-617 can be used to prolong life and reduce tumor burden in terminally ill castration resistant prostate cancer patients. Still, accumulation in healthy tissue limits the activity that can be administered. Therefore,… read more here.
Keywords: three cycles; psma 617; toxicity; high activity ... See more keywords
Dynamic Change of Peripheral Blood WT1-mRNA within Three Cycles of Azacitidine Therapy Predicts Treatment Response in High-Risk Myelodysplastic Syndrome
Sign Up to like & getrecommendations! Published in 2020 at "Blood"
DOI: 10.1182/blood-2020-138377
Abstract: Introduction. Hypomethylating agents azacitidine (AZA) and decitabine are standard of care for myelodysplastic syndromes (MDS). Considering the result of the secondary analysis of the AZA-001 trial showing 91% of first responses occurred within 6 cycles,… read more here.
Keywords: wt1 mrna; response; three cycles; cycles aza ... See more keywords
Two or three cycles of induction chemotherapy in locoregionally advanced nasopharyngeal carcinoma?
Sign Up to like & getrecommendations! Published in 2025 at "BMC Cancer"
DOI: 10.1186/s12885-025-14699-4
Abstract: To investigate the optimal cycles of induction chemotherapy (IC) in patients with locoregionally advanced nasopharyngeal carcinoma (LANPC). We included LANPC patients treated with two or three IC cycles from January 2015 to December 2021. The… read more here.
Keywords: three cycles; induction chemotherapy; cycles induction; advanced nasopharyngeal ... See more keywords